Egesta Lopci

53PUBLICATIONS
104CO-AUTHORS
Haematological tumoursAdolescent healthMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jul 28, 2026
Molecular, Biochemical, and Bioimaging Markers of MEN Syndromes.

|Jun 03, 2026
EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

|Mar 14, 2026
Cost Analysis of PSMA-PET in the PROSPET-BX Trial.

Egesta Lopci, Cesare Saitta, Alberto Saita

|Mar 12, 2026
Immunoprofiling, sex- and age-related determinants of treatment response in paediatric, adolescent and young adult Hodgkin lymphoma.

Valli De Re, Egesta Lopci, Giulia Brisotto

|Mar 09, 2026
Malignant Pleural Mesothelioma (MPM) Evaluation with [11C]-Methionine PET/CT Before and After Talc Pleurodesis.

Egesta Lopci, Angelo Castello, Alberto Testori

|Mar 05, 2026
[68Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX).

Egesta Lopci, Massimo Lazzeri, Alberto Saita

Pageof 9

Frequent Collaborators

5 joint publications

Laurent Dercle

5 joint publications

Massimo Castellani

4 joint publications

Samy Ammari

4 joint publications

Maurizio Mascarin